DUXAP8 and hepatocellular carcinoma: In addition, the knockdown of DUXAP8 significantly represses epithelial-mesenchymal transition (EMT) in lung cancer and hepatocellular carcinoma.27,28 However, the biological functions of DUXAP8 in BC have not been elucidated.